We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+12.92%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$1.45B
AUM Growth
+$498M
Cap. Flow
+$399M
Cap. Flow %
27.57%
Top 10 Hldgs %
76.54%
Holding
380
New
91
Increased
20
Reduced
24
Closed
242

Top Buys

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$75.5M
2
AES icon
AES
AES
+$43.8M
3
GLD icon
SPDR Gold Trust
GLD
+$25.5M
4
SLV icon
iShares Silver Trust
SLV
+$22.9M
5
AAPL icon
Apple
AAPL
+$16.8M

Top Sells

Rank Stock Value
1
HES
Hess
HES
+$41.5M
2
CTRA
Coterra Energy
CTRA
+$36.3M
3
EQNR icon
Equinor
EQNR
+$30.9M
4
EQT icon
EQT Corp
EQT
+$29.6M
5
OPTU
Optimum Communications Inc
OPTU
+$19M

Sector Composition

Rank Sector Weight
1 Utilities 12.18%
2 Technology 9.77%
3 Consumer Discretionary 4.85%
4 Healthcare 0.76%
5 Communication Services 0.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLF icon
126
CALL
State Street Financial Select Sector SPDR ETF
XLF
$58.8B
$116K 0.01%
4,000
-71,000
-95% -$1.9M
EXTR icon
127
Extreme Networks
EXTR
$3.17B
$113K 0.01%
+16,422
New +$88.2K
VKTX icon
128
Viking Therapeutics
VKTX
$4B
$112K 0.01%
+19,901
New +$121K
HAPN
129
Happen Inc
HAPN
$2.25B
$111K 0.01%
+10,527
New +$70.4K
CMCM
130
Cheetah Mobile
CMCM
$98.1M
$104K 0.01%
11,538
-7,543
-40% -$75K
ALTO icon
131
Alto Ingredients
ALTO
$325M
$89K 0.01%
+16,337
New +$113K
PRTY
132
DELISTED
Party City Holdco Inc.
PRTY
$87K 0.01%
+14,076
New +$54.7K
CPRX
133
DELISTED
Catalyst Pharmaceutical
CPRX
$82K 0.01%
24,592
+13,039
+113% +$43.8K
RES icon
134
RPC Inc
RES
$1.36B
$79K 0.01%
+25,119
New +$75.5K
LXRX icon
135
Lexicon Pharmaceuticals
LXRX
$1.09B
$37K ﹤0.01%
+10,747
New +$20.5K
BBAR icon
136
BBVA Argentina
BBAR
$3.52B
$36K ﹤0.01%
+11,288
New +$33.5K
A icon
137
Agilent Technologies
A
$41.9B
-4,043
Closed -$408K
AAPL icon
138
CALL
Apple
AAPL
$4.48T
-30,000
Closed -$3.47M
AFL icon
139
Aflac
AFL
$60.9B
-7,621
Closed -$277K
AIV
140
Aimco
AIV
$378M
-45,056
Closed -$202K
AKAM icon
141
Akamai
AKAM
$16.9B
-3,035
Closed -$335K
AKR icon
142
Acadia Realty Trust
AKR
$2.78B
-15,178
Closed -$159K
ALGN icon
143
Align Technology
ALGN
$12.5B
-1,047
Closed -$343K
AMED
144
DELISTED
Amedisys
AMED
-6,551
Closed -$1.55M
ANSS
145
DELISTED
Ansys
ANSS
-656
Closed -$215K
APPF icon
146
AppFolio
APPF
$7.04B
-1,790
Closed -$254K
ARGX icon
147
argenx
ARGX
$54.3B
-1,013
Closed -$266K
ARR
148
Armour Residential REIT
ARR
$2.34B
-2,291
Closed -$109K
ATRO icon
149
Astronics
ATRO
$3.72B
-12,913
Closed -$83K
AVGO icon
150
Broadcom
AVGO
$2.02T
-16,400
Closed -$597K

Similar funds

Caxton Associates (New York)'s Q4 2020 Portfolio in Review

As of Q4 2020, Caxton Associates (New York) held 380 positions worth $1.45B, up 52% from $950M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Caxton Associates (New York) deployed $399M of net new capital in Q4 2020, opening 91 new positions and adding to 20 existing holdings. Its largest new stake was AES: 2,105,805 shares worth $49.5M.

By sector, the portfolio is most concentrated in Utilities at 12% of assets, up from 0.06% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Optimum Communications Inc, an estimated $19M trimmed.

  • Caxton Associates (New York)'s largest Q4 2020 buy was AES: 2,105,805 shares worth $49.5M.
  • Caxton Associates (New York) added most to iShares MSCI Emerging Markets ETF in Q4 2020, an estimated $75.5M increase.
  • Caxton Associates (New York)'s biggest Q4 2020 reduction was Optimum Communications Inc, cutting an estimated $19M.
  • Caxton Associates (New York) fully exited Hess in Q4 2020, selling an estimated $41.5M.
  • Caxton Associates (New York)'s ten largest holdings make up 77% of its $1.45B portfolio in Q4 2020.
  • Caxton Associates (New York) opened 91 new positions and closed 242 in Q4 2020.
  • Caxton Associates (New York)'s portfolio value rose 52% quarter-over-quarter to $1.45B.

Based on Caxton Associates (New York)'s 13F filing for Q4 2020, filed 16 Feb 2021.